Clinical Trial - Endovascular Treatment for Basilar Artery Occlusion
Considerations
- 1% of all strokes; 6-8% of EVT
- Symptoms: impaired consciousness, quadriparesis, pupillary abnormality, vertigo, and hearing loss
- Mortality rate 36%, and only 32% achieved positive clinical outcomes
- Location: top is embolus, mid is stenosis
Clinical trials (EVT vs BMM)
BEST (2020)
- no difference in function or mortality
BASICS (2021)
- no difference in function or mortality
ATTENTION (2022)
- better function and mortality
BAOCHE (2022)
- better function, but no difference in mortality
